Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution

Download PDF

Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy

Link

Targeting GD2 with naxitamab overcomes GD3 synthase-driven immune suppression in triple-negative breast cancer

Link

"*" indicates required fields

X/Twitter

This field is for validation purposes and should be left unchanged.

Salutation*

First Name*

Last Name*

Email*

Country/Region*

Institution/Company*

Industry*

Position*

Research area*

Organ*

Stage of research*

Does your laboratory perform stainings on tissue samples?*

Consent*

I agree to receive relevant information and updates from Lunaphore about its products. You can unsubscribe from this list at any time. For further information please review the Privacy Policy and Legal Statement on our website.

CAPTCHA

Legal Privacy Cookie Policy Terms and Conditions Cookie Settings

Tolochenaz, Switzerland

[email protected]

+41 21 353 58 10

COMET™ is CE/UKCA/UL marked and is For Research Use Only.
Not for use in diagnostic procedures.

Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution

Related Articles

Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy

Targeting GD2 with naxitamab overcomes GD3 synthase-driven immune suppression in triple-negative breast cancer